Puma Biotechnology (PBYI) Other Non-Current Assets (2011 - 2026)

Puma Biotechnology (PBYI) has 16 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 26.52% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 26.52% YoY) and the FY2025 annual result came in at $2.7 million, up 27.29% from the prior year.
• Other Non-Current Assets retreated to $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q1 2022 to a low of $217000.0 in Q3 2022.
• A 5-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 93.45% — and 2023, when it soared 1162.67%.
• Tracing PBYI's Other Non-Current Assets over 5 years: stood at $2.1 million in 2022, then climbed by 1.5% to $2.1 million in 2023, then changed by 0.0% to $2.1 million in 2024, then increased by 27.29% to $2.7 million in 2025, then retreated by 0.6% to $2.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $2.1 million (Q2 2025), per Business Quant data.